BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 21721018)

  • 1. An intravenous exposure mouse model for prediction of potential drug-sensitization using reporter antigens popliteal lymph node assay.
    Lin M; Sun W; Wang Y; Li X; Jin Y; Gong W; Fan X; Wang Y
    J Appl Toxicol; 2012 Jun; 32(6):395-401. PubMed ID: 21721018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an oral exposure mouse model to predict drug-induced hypersensitivity reactions by using reporter antigens.
    Nierkens S; Aalbers M; Bol M; van Wijk F; Hassing I; Pieters R
    Toxicol Sci; 2005 Feb; 83(2):273-81. PubMed ID: 15509662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the TNP-OVA and direct popliteal lymph node assays for the detection of immunostimulation by drugs associated with anaphylaxis in humans.
    Gutting BW; Updyke LW; Amacher DE
    J Appl Toxicol; 2002; 22(3):177-83. PubMed ID: 12015798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diesel exhaust, carbon black, and silica particles display distinct Th1/Th2 modulating activity.
    van Zijverden M; van der Pijl A; Bol M; van Pinxteren FA; de Haar C; Penninks AH; van Loveren H; Pieters R
    Toxicol Appl Pharmacol; 2000 Oct; 168(2):131-9. PubMed ID: 11032768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the immunosensitizing potential of chlorogenic acid using a popliteal lymph node assay in BALB/c mice.
    Liu Z; Liu Z; Shi Y; Zhou G
    Food Chem Toxicol; 2010 Apr; 48(4):1059-65. PubMed ID: 20122982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral exposure to drugs with immune-adjuvant potential induces hypersensitivity responses to the reporter antigen TNP-OVA.
    Kwast LM; Fiechter D; Hassing I; Bleumink R; Boon L; Ludwig IS; Pieters RH
    Toxicol Sci; 2011 Jun; 121(2):312-9. PubMed ID: 21402728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses induced by diclofenac or carbamazepine in an oral exposure model using TNP-Ficoll as reporter antigen.
    Kwast L; Aida T; Fiechter D; Kruijssen L; Bleumink R; Boon L; Ludwig I; Pieters R
    J Immunotoxicol; 2016 Nov; 13(6):918-926. PubMed ID: 27967303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diclofenac activates T cells in the direct popliteal lymph node assay and selectively induces IgG(1) and IgE against co-injected TNP-OVA.
    Gutting BW; Updyke LW; Amacher DE
    Toxicol Lett; 2002 May; 131(3):167-80. PubMed ID: 11992736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune modulation by cadmium and lead in the acute reporter antigen-popliteal lymph node assay.
    Carey JB; Allshire A; van Pelt FN
    Toxicol Sci; 2006 May; 91(1):113-22. PubMed ID: 16495351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of reporter antigens in the popliteal lymph node assay to assess immunomodulation by chemicals.
    Albers R; Broeders A; van der Pijl A; Seinen W; Pieters R
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):102-9. PubMed ID: 9073598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BALB/c mice orally pretreated with diclofenac have augmented and accelerated PLNA responses to diclofenac.
    Gutting BW; Updyke LW; Amacher DE
    Toxicology; 2002 Apr; 172(3):217-30. PubMed ID: 11893420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The allergy adjuvant effect of particles - genetic factors influence antibody and cytokine responses.
    Nygaard UC; Aase A; Løvik M
    BMC Immunol; 2005 Jun; 6():11. PubMed ID: 15967044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response.
    Bliss J; Van Cleave V; Murray K; Wiencis A; Ketchum M; Maylor R; Haire T; Resmini C; Abbas AK; Wolf SF
    J Immunol; 1996 Feb; 156(3):887-94. PubMed ID: 8558014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the use of reporter antigens in an auricular lymph node assay to assess the immunosensitizing potential of drugs.
    Nierkens S; Nieuwenhuijsen L; Thomas M; Pieters R
    Toxicol Sci; 2004 May; 79(1):90-7. PubMed ID: 14976356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Popliteal lymph node assay: facts and perspectives.
    Ravel G; Descotes J
    J Appl Toxicol; 2005; 25(6):451-8. PubMed ID: 15986413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the direct and reporter antigen popliteal lymph node assay for the detection of immunomodulation by low molecular weight compounds.
    Gutting BW; Schomaker SJ; Kaplan AH; Amacher DE
    Toxicol Sci; 1999 Sep; 51(1):71-9. PubMed ID: 10496678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Popliteal lymph node (PLN) assay to study adjuvant effects on respiratory allergy.
    Løvik M; Alberg T; Nygaard UC; Samuelsen M; Groeng EC; Gaarder PI
    Methods; 2007 Jan; 41(1):72-9. PubMed ID: 17161303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergy adjuvant effect of particles from wood smoke and road traffic.
    Samuelsen M; Nygaard UC; Løvik M
    Toxicology; 2008 Apr; 246(2-3):124-31. PubMed ID: 18289765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of autoimmunogenic potential of xenobiotics using the popliteal lymph node assay.
    Pieters R; Albers R
    Methods; 1999 Sep; 19(1):71-7. PubMed ID: 10525440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coadministration of antigen and particles optimally stimulates the immune response in an intranasal administration model in mice.
    van Zijverden M; de Haar C; van Beelen A; van Loveren H; Penninks A; Pieters R
    Toxicol Appl Pharmacol; 2001 Dec; 177(3):174-8. PubMed ID: 11749116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.